Labcorp — Jul 24, 2025 release

sted EPS and Free Cash Flow guidance: ◦ Revenue guidance narrowed to 7.5% to 8.6%; midpoint raised by 70 basis points ◦ Adjusted EPS range narrowed to $16.05 to $16.50; midpoint raised by $0.23 ◦ Free Cash Flow range of $1.13 billion to $1.28 billion; midpoint raised by $25 million • Broadened our partnerships with hospitals, health systems and regional/local labs and enhanced access to comprehensive testing and laboratory services • Introduced several new tests in high-growth specialty areas including oncology BURLINGTON, N.C., July 24, 2025 – Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the second quarter ended June 30, 2025 and raised full-year guidance. “Labcorp had a very strong second quarter, delivering double-digit topline growth, while expanding margins across both segments,” said Adam Schechter, chairman and CEO of Labcorp. “We brought innovative tests to market, and applied our leadership in science and technology to drive growth, enhance the customer experience and improve our operations.  We remain committed to delivering sustained value to our customers, employees and shareholders as we execute on our long-term strategy. Based upon our performance in the first half and our momentum going into the second half of the year, we’re raising our guidance.” 1 In the second quarter, Labcorp advanced its position as a partner of choice for hospitals, h